The pyrrolizidine alkaloid, fulvine, is now accepted as a major cause of veno-occlusive disease of the liver in the West Indies, where it is ingested as a decoction of the plant Crotalaria fulva in bush tea. Fulvine is similar in chemical structure to monocrotaline, which is known to cause pulmonary hypertension in rats.
The pyrrolizidine alkaloid, fulvine, is now accepted as a major cause of veno-occlusive disease of the liver in the West Indies, where it is ingested as a decoction of the plant Crotalaria fulva in bush tea. Fulvine is similar in chemical structure to monocrotaline, which is known to cause pulmonary hypertension in rats.
Thirty young female rats were given a single dose of fulvine either by intraperitoneal injection (50 mg/kg body weight) or by stomach tube (80 mg/kg body weight). Eleven of these rats died of acute haemorrhagic centrilobular necrosis of the liver, and two of pneumonia, within 23 days of receiving fulvine. These 13 showed no evidence of hypertensive pulmonary vascular disease. The remaining 17 rats (which survived from 24 to 37 days) developed hypertensive pulmonary vascular disease with right ventricular hypertrophy together with medial thickening of the pulmonary trunk and muscular pulmonary arteries. The pulmonary arterioles showed hypertensive changes and some contained thrombi. In four animals an acute necrotizing arteritis also occurred.
We have shown that fulvine resembles monocrotaline in its ability to produce pulmonary hypertension in rats. We suggest that, in any patient presenting with unexplained pulmonary hypertension, a careful enquiry should be made to elicit the possibility of recent ingestion of drugs or plant extracts that may have caused a rise in the pulmonary arterial pressure.
Fulvine is a pyrrolizidine alkaloid contained in the foliage and seeds of Crotalaria fulva (Schoental, 1963) . This leguminous plant is one of several which are used in the West Indies for the preparation of bush teas, which are consumed by the indigenous population for medicinal and other purposes. It is now generally accepted that fulvine and possibly other pyrrolizidine alkaloids contained in bush tea are the cause of veno-occlusive disease of the liver in the West Indies (Bras, Berry, and Gyorgy, 1957 ; Bras and McLean, 1963) CH2-O monest cause of hepatic cirrhosis in Jamaica (Bras, Brooks, and Watler, 1961) . Fulvine is closely related to monocrotaline ( Fig. 1) , a pyrrolizidine alkaloid contained in Crotalaria spectabilis. We have previously shown that when monocrotaline is given to rats by the oral or systemic routes they develop severe pulmonary arterial hypertension (Kay, Harris, and Heath, 1967) . This is associated with right ventricular hypertrophy and thickening of the pulmonary trunk and muscular pulmonary arteries (Kay and Heath, 1966; Heath and Kay, 1967) . In about one-third of affected animals an acute necrotizing pulmonary arteritis also occurs. There have been several studies of the effect of fulvine on the liver (Barnes, Magee, and Schoental, 1964;  McLean, Bras, and Gyorgy, 1964;  Gardiner, Royce, and Bokor, 1965) but no adequate investigation of its effect on the heart and lungs. In view of the close chemical similarity of fulvine and monocrotaline we decided to study the heart and pulmonary arteries of rats given fulvine to see if this alkaloid would also produce hypertensive pulmonary vascular disease. 16   10  83  2238  496  3189  4-51  0 44  5-6  17  7  120  2736  785  3722  3-48  0-55  5 1  18  10  102  1465  674   2292  2-17  0-46  3-9  19  15  165  2443  596  3290  4-10  0-38  6 5  20  23  295  2806  1045  4200  2-68  0-41  3 0  21  35  122  3610  3016  7320  1 20  0-98  13-5  22   23  80  2491  890  3863  2-80  0- When fixation was complete the heart was opened. Blood and excess fixative were removed by blotting with fine gauze, and the cardiac chambers were divided using the method described by Fulton, Hutchinson, and Morgan Jones (1952) . The free wall of the right ventricle was dissected from the remainder of the heart and weighed. The left ventricle with the attached interventricular septum were weighed together, and the two atria were weighed together. The presence of right ventricular hypertrophy was assessed by expressing the weight of the free wall of the right ventricle as an inverse ratio of the weight of the left ventricle and interventricular septum. The use of this ratio excludes the influence of body weight in making comparisons of right ventricular mass. The greater the degree of right ventricular hypertrophy, the smaller the ratio of left to right ventricular weight.
Blocks of tissue were taken from the left lung and from each of the superior, middle, inferior, and median lobes of the right lung. Sections of paraffinembedded tissue were cut at 5,u thickness and stained with haemotoxylin and eosin, by the elastic-van Gieson technique described above, by Perls' method for demonstrating ferric iron, and by the MartiusScarlet-Blue method for fibrin (Lendrum, Fraser, Slidders, and Henderson, 1962) . Sections stained by the elastic-van Gieson method were examined with a microscope fitted with a calibrated eyepiece micrometer for measurement of the medial thickness and external diameter of muscular pulmonary arteries. Muscular pulmonary arteries consist of a muscular media bounded by internal and external elastic laminae. A total of between 10 and 40 such arteries (mean 22) was examined in each of the control and test rats. Only arteries which were virtually circular in transverse section were measured. The external diameter was taken as the mean of two measurements, at right angles to each other, of the distance between diametrically opposite points on the external elastic lamina. The medial thickness was estimated as the mean of four measurements taken at approximately equally spaced points around the vessel waLL Sections of paraffin-embedded liver tissue were stained with haematoxylin and eosin and by Gomori's (1950) (Tables IV and V) . The volume ranged from less than 10 ml to as much as 125 ml. The fluid was clear and watery in five cases and bloodstained in seven. Pleural effusions were seen in 15 test rats. In 11 cases there was an associated ascites, while in four cases the pleural effusions were solitary (Tables IV and  V) . The pleural fluid was clear and watery in nine cases but haemorrhagic in the remainder. Three tests rats (nos 3, 20, and 27) showed subcutaneous oedema of the anterior abdominal and thoracic walls.
The untreated control rats showed no abnormality at necropsy.
CAUSE OF DEATH Assessment of the right ventricular weight and subsequent histological examination of the liver, lungs, and pulmonary vasculature revealed that 11 of the 30 test rats died of an extensive haemorrhagic centrilobular necrosis of the liver, and two of pneumonia within 23 days of receiving fulvine. The remaining 17 rats survived longer than 23 days, developed hypertensive pulmonary vascular disease, and eventually died of right ventricular failure. The rats which died of liver disease or pneumonia showed no signs of hypertensive pulmonary vascular disease, while animals dying of right ventricular failure showed relatively insignificant hepatic lesions. The cause of death in each test rat is given in Tables IV and V. In the following paragraphs we show the development of right ventricular hypertrophy and describe the pulmonary vascular and parenchymal lesions. We shall not deal with the hepatic lesions in this paper because they have previously been described in detail by other workers (Barnes et al., 1964; McLean et al., 1964) .
Right ventricular hypertrophy The total heart weight, the weights of the individual ventricles, and the right ventricular weight expressed as an inverse ratio of the weight of the left ventricle and interventricular septum (LV+S/RV) are shown in Tables I, II , and III. Figure 2 shows the relation between survival time and the LV + S/RV ratio in the test and control rats. According to Fulton et al. (1952) , isolated right ventricular hypertrophy may be considered to be present in man when the LV +S/RV ratio is less than 2-0. This criterion for the assessment of right ventricular hypertrophy also applies in the rat (Kay and Heath, 1969) . The graph shows that there was no evidence of right ventricular hypertrophy in the 13 test rats which died within 23 days of receiving a single dose of fulvine, since in these animals the LV+ S/RV ratio was greater than 2-0. The test rats which survived longer than 23 days all showed quantitative evidence of right ventricular hypertrophy because the LV+S/RV ratio was less than 2-0. The pulmonary blood vessels of the 13 rats without right ventricular hypertrophy which died of liver disease or pneumonia within 23 days of receiving fulvine were normal. The 17 rats which survived longer than 23 days and developed right ventricular hypertrophy all showed evidence of hypertensive pulmonary vascular disease. Lesions were present in the pulmonary trunk, muscular pulmonary arteries, pulmonary arterioles, and alveolar capillaries. The distribution of the various lesions in the test rats is summarized in Tables IV  and V.   253 group.bmj.com on June 16, 2017 -Published by http://thorax.bmj.com/ Downloaded from PULMONARY TRUNK The tunica media of the pulmonary trunk in normal rats consists of several long, unbranched, concentric elastic laminae separated from one another by circularly orientated smooth muscle fibres (Fig. 3) . This musculoelastic media is sharply delineated from the intimal endothelial cell layer on its inner aspect, and from the thick fibrous adventitia on its outer aspect. The pulmonary trunk in the 17 test rats with right ventricular hypertrophy showed medial thickening due to the development of new muscle in between the elastic laminae causing them to be widely separated (Fig. 4) . Some of these elastic laminae were uneven, branched, and even fragmented. Fine elastic fibrils were seen between the main laminae. The external elastic lamina was indistinct and there was a proliferation of smooth muscle in the adventitia. Figure 5 shows the relation between the medial thickness of the pulmonary trunk and survival time in control and test rats. The medial thickness of the pulmonary trunk has been expressed as a ratio of the medial thickness of the aorta (PT/A ratio). In man the PT/A ratio does not normally exceed 0-7 after the age of 2 years (Heath, Wood, Du Shane, and Edwards, 1959) , and this criterion for assessing the presence of medial hypertrophy of the pulmonary trunk also applies to the rat (Kay and Heath, 1969) . The graph reveals that the animals with right ventricular hypertrophy also show measurable medial thickening of the pulmonary trunk. The PT/A ratio in each of the control and test rats is given in Tables I, II, and III. MUSCULAR PULMONARY ARTERIES We define a muscular pulmonary artery in a rat to be an arterial vessel with an external diameter lying between 20,u and 400,u. It has a media of circularly orientated smooth muscle fibres which does not normally exceed 7% of this external diameter (Fig. 6) ; the media is bounded by internal and external elastic laminae (Kay and Heath, 1966 average medial thickness ranging from 9-6% to 16-6% (Fig. 7) . The thickened media consisted of circularly orientated smooth muscle fibres (Fig. 8) ; no longitudinal muscle was found, neither was there any form of intimal proliferation. The average percentage medial thickness for each of the test and control rats is given in Tables I, II, and III. In 4 of the 17 test rats with hypertensive pulmonary vascular disease, several of the larger muscular pulmonary arteries ranging in external diameter from 200,u to 400t showed an acute necrotizing arteritis (Fig. 9) The pulmonary arterioles of all the 17 rats which developed right ventricular hypertrophy showed hypertensive changes with the development of a thick medial coat of circular muscle bounded by internal and external elastic laminae (Fig. 10) . In 10 of these 17 rats, the thickened walls of many of the pulmonary arterioles showed an intense hyaline eosinophilia and staitied by the Martius-Scarlet-Blue method for fibrin (Fig. 11) (Fig. 13) . A proliferation of alveolar cells occurred in all 17 of the rats with hypertensive pulmonary vascular disease. These cells were either attached to the alveolar walls or lay apparently free in the alveolar spaces. In 16 rats some of these cells contained a brown intracytoplasmic pigment which stained by Perls's method for ferric iron, indicating that these cells were macrophages. The majority of alveolar cells, however, did not contain stainable iron. These cells were large (up to 25,u diameter) and possessed cytoplasm that was either eosinophilic and granular, or contained numerous small vacuoles, producing a foamy appearance. Their nuclei were large and vesicular, sometimes containing one or two prominent occluded by thrombi (Fig. 12) . These thrombotic lesions were frequently accompanied by focal haemorrhages into the surrounding alveolar spaces.
LESIONS IN THE LUNG PARENCHYMA
The parenchymal lesions which occurred in the lungs of the 30 test rats are listed in Tables IV and V. Infective lesions consisting of either bronchopneumonia or multiple pyaemic abscesses were noted in seven test rats. A severe confluent bronchopneumonia was considered to be the cause of death in two animals (nos 11 and 22) which showed no signs of major hepatic disease or right ventricular failure. No significant infective lesions were seen in the lungs of any of the 10 control rats.
The lungs of all the 17 test rats with right ventricular hypertrophy and hypertensive pulmonary vascular disease showed parenchymal lesions which appeared to be the direct or indirect result of exudation of blood or plasma from the small pulmonary blood vessels into the alveolar walls nucleoli. Precise identification of alveolar cells was impossible, but their cytological features suggested that they were granular pneumocytes. In three of the rats (nos 1, 4, and 10) with pulmonary vascular disease some of the alveoli were lined by low columnar cells resembling bronchiolar epithelium.
In contrast to the 17 test rats with right ventricular failure, the 11 animals which died of hepatic necrosis showed few exudative lesions in the lung parenchyma. Extensive haemorrhage was observed in one animal, and alveolar siderophages in two animals, but in each instance these lesions accompanied bronchopneumonia or pyaemic abscesses (Tables IV and V) . A proliferation of alveolar cells occurred in one rat with hepatic necrosis.
DISCUSSION
Fulvine and possibly other pyrrolizidine alkaloids are now generally accepted as causing hepatic veno-occlusive disease in Jamaica, and the programme of health education on the island has apparently reduced the incidence of the disease. McFarlane and Branday (1945) described hepatic enlargement and ascites in Jamaican children, which they diagnosed as hepatitis of unknown aetiology, implying that cirrhosis of the liver might be the ultimate result. Royes (1948) concluded that these cases presented a picture of portal cirrhosis very similar to that described in India and Egypt. Hill, Rhodes, Stafford, and Aub (1953) presented their findings in such children and they called the disease serous hepatosis. The occurrence of occlusion of the small hepatic vein radicals in children with this clinical syndrome was first described by Bras, Jelliffe, and Stuart (1954) . They proposed the name veno-occlusive disease by which the condition is now widely known. The disease progresses clinically through three overlapping stages (Stuart and Bras, 1957) . The acute phase commonly affects young children and is manifested by a sudden onset of ascites and hepatomegaly. In this acute phase there is blockage of the small hepatic veins due to swelling of the intimal tissues. Initially the swelling is oedematous and it may contain a varying amount of blood, but later it becomes organized. There is an intense centrilobular congestion surrounding the blocked veins with loss of liver cells. These acute features have recently been described by Brooks et al. (1970) in electron microscopic studies. The dominant clinical feature of the subacute stage is persistent, often symptomless, hepatomegaly. The underlying pathology is persistent fibrosis in non-portal areas, and blocked centrilobular veins are a regular feature. The clinical picture of the chronic phase is that of cirrhosis of the liver and its complications. The pathology of this phase is a non-portal cirrhosis; in cases of long standing the origin of the cirrhosis becomes irretraceable.
Bras and his co-workers Bras and McLean, 1963) (Brooks et al., 1970; Allen, Carstens, and Olson, 1967; Allen, Carstens, and Katagiri, 1969) , while in rodents (McLean et al., 1964; Selzer, Parker, and Sapeika, 1951) , chickens (Allen, Childs, and Cravens, 1960; Simpson, Waldroup, and Harms, 1963) , and swine (Emmel, Sanders, and Henley, 1935) hepatic necrosis is primary and the venous lesions are only occasionally observed.
The present experiment clearly shows that fulvine will not only produce centrilobular necrosis and veno-occlusive lesions in rats but can also cause hypertensive pulmonary vascular disease in them. This is manifested by right ventricular hypertrophy together with thickening of the pulmonary trunk, medial thickening of the muscular pulmonary arteries, and muscularization of the pulmonary arterioles. Although we did not measure the pulmonary arterial pressure in this experiment, the pulmonary vascular lesions are identical with those which occur in rats given the closely related alkaloid, monocrotaline (Kay and Heath, 1966; Heath and Kay, 1967) , and in which we have demonstrated a severe degree of pulmonary arterial hypertension by cardiac catheterization (Kay et al., 1967b) . The acute pulmonary arteritis which occurs in rats treated with monocrotaline and fulvine is probably due to a sudden, severe increase in the pulmonary arterial pressure causing necrosis of the vessel wall (Kay and Heath, 1966) .
At the dosage of fulvine used in this experiment, rats either died of massive hepatic necrosis within 23 days or survived longer to develop hypertensive pulmonary vascular disease and eventually succumb to right ventricular failure. The higher intragastric dose of fulvine produced 10 early deaths from hepatic necrosis and four late deaths due to right ventricular failure. The lower intraperitoneal dose of fulvine resulted in only one early death from hepatic necrosis, while 13 rats died later from right ventricular failure. We think that if the animals survive the early phase of liver necrosis they will all eventually develop hypertensive pulmonary vascular disease: perhaps the two test rats which died of pneumonia on the 22nd and 23rd days of the experiment would have developed hypertensive pulmonary vascular disease had they survived longer. These animals showed no hepatic necrosis, but there was quantitative evidence of early thickening of the muscular pulmonary arteries (Fig. 7) and pulmonary trunk (Fig. 5) (Barnes et al., 1964) .
The lungs of the 17 rats which developed hypertensive pulmonary vascular disease and died of right ventricular failure after receiving fulvine showed old and recent haemorrhage, alveolar fibrinous exudate, interstitial fibrosis, and a proliferation of alveolar cells. These parenchymal lesions are identical with those which occur in the lungs of rats treated with monocrotaline. They have been termed exudative lesions (Kay, Gillund, and Heath, 1967a) since they could all be the direct or indirect result of chronic exudation of blood or plasma from the small pulmonary blood vessels into the alveolar walls and spaces. Such exudation could result from an alteration in the capillary permeability or to an increase in the capillary intraluminal blood pressure. In all the 17 rats with hypertensive pulmonary vascular disease, many of the alveolar capillaries were occluded by thrombi. The presence of these occlusive lesions would probably increase the capillary intraluminal blood pressure and thus lead to the development of the exudative and proliferative lesions in the lung parenchyma.
There are in the literature two other descriptions of pulmonary lesions in animals treated with fulvine. Gardiner et al. (1965) describe interstitial fibrosis and a proliferation of alveolar cells in rabbits given subcutaneous injections of fulvine but do not mention the heart or pulmonary blood vessels. Barnes et al. (1964) gave a single oral 259 group.bmj.com on June 16, 2017 -Published by http://thorax.bmj.com/ Downloaded from dose of fulvine to rats (50 mg per kg body weight) and found that in animals which died within a few days there was an acute necrosis of the liver but the lungs were virtually normal. In contrast, the rats which died from 22 to 68 days after receiving fulvine showed severe lung lesions while the livers were normal apart from the nutmeg pattern of chronic centrilobular venous congestion in some of them. They describe thickened alveolar walls, alveolar oedema and haemorrhage, and a proliferation of large alveolar cells. They also describe and illustrate acute pulmonary arteritis. They state that while there was an impression of an increase in the size of the heart, it was difficult to say whether there was any significant right ventricular hypertrophy. Barnes and his colleagues did not carry out a complete examination of the heart and lungs in their experiments and so did not appreciate the functional significance of the lesions which they observed. They were unable to explain the occurrence of pleural effusions in rats dying with normal livers and damaged lungs several weeks after a single injection of fulvine. Such effusions were no doubt a manifestation of right ventricular failure produced by the hypertensive pulmonary vascular disease which, although present, they had not recognized.
The mechanism by which fulvine and monocrotaline produce pulmonary hypertension is not clear. The possible roles played by changes in alveolar capillaries, alveolar hypoxia, pulmonary mast cell hyperplasia, and 5-hydroxytryptamine have been discussed elsewhere (Kay, Smith, and Heath, 1969) . One of the most intriguing problems is that latent period of several weeks which elapses between the administration of the alkaloid and the development of the pulmonary vascular lesions. There is evidence that the pyrrolizidine alkaloids themselves are not toxic substances, but that they are dehydrogenated in the liver to produce highly reactive pyrroll derivatives, which may then be transported to the lungs. It has been shown that the metabolism and excretion of a single toxic dose of a pyrrolizidine alkaloid takes place rapidly and is virtually complete within 24 hours (Mattocks, 1968) . Thus the delayed onset of the pulmonary vascular disease cannot result from a prolonged exposure to a toxic metabolite circulating in the blood for several weeks but must follow a short exposure during the metabolism orf the alkaloid (Butler, Mattocks, and Barnes, 1970) .
Fulvine is now the third substance which has been shown to produce hypertensive pulmonary vascular disease when ingested by rats. We have previously shown that when rats are fed on a diet adulterated with Crotalaria spectabilis seeds which contain monocrotaline, they develop pulmonary arterial hypertension with right ventricular hypertrophy and vascular lesions in the lungs (Kay et al., 1967b) . Dr. J. Burns, working in our laboratory at Liverpool, has recently shown that the oral administration of Senecio jacobaea (ragwort) to rats produces right ventribular hypertrophy and hypertensive pulmonary vascular disease. Senecio jacobaea contains six pyrrolizidine alkaloids (Bull, Culvenor, and Dick, 1968) , and preparations of it are freely available from herbalists and so-called 'health stores' in Britain where they are recommended for the treatment of various ailments.
Although in this paper we have shown that cor pulmonale can occur in association with hepatic veno-occlusive disease in rats, pulmonary vascular disease has never been reported in human cases of veno-occlusive disease of the liver in Jamaica.
Our studies convince us that in all patients presenting with unexplained pulmonary hypertension, a careful enquiry should be made into the possibility that the disease might be related to the ingestion of a drug or plant extract. In a separate paper in this journal (Kay, Smith, and Heath, 1971) , we review the evidence linking aminorex, a widely used anorexigen, with an epidemic of primary pulmonary hypertension which occurred recently in western Europe.
